Veterinary Medicines

RABISIN, ενέσιμο εναιώρημα

Authorised
  • Rabies virus, strain G52, Inactivated
Download as PDF

Product identification

Medicine name:
RABISIN, ενέσιμο εναιώρημα
Active substance:
  • Rabies virus, strain G52, Inactivated
Target species:
  • Horse
  • Cattle
  • Sheep
  • Dog
  • Cat
  • Ferret
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain G52, Inactivated
    2.09
    log10 optical density50
    /
    1.00
    dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Not applicable
        no withdrawal period
    • Cattle
      • Not applicable
        no withdrawal period
    • Sheep
      • Not applicable
        no withdrawal period
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
    • Ferret
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Cattle
      • Not applicable
        no withdrawal period
    • Sheep
      • Not applicable
        no withdrawal period
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
    • Ferret
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 57429/02-06-2020/K-0013001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 21/08/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 21/08/2024
Download